Auckland Clinical Studies   Report issue

For profit Phase 1 Phase 2
Founded: Auckland New Zealand (2006)

Organization Overview

First Clinical Trial
2007
NCT00522808
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ACS New Zealand | Auckland Clinical Services | Auckland Clinical studies | Auckland Clinical Studies | Auckland Clinical Studies (ACS), | Auckland Clinical Studies (ACS) Ltd. | Auckland Clinical Studies Limited | Auckland Clinical Studies Ltd | Ed Gane, ACS New Zealand

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Infections (Phase 2)

Ornithine Carbamoyltransferase Deficiency Disease (Phase 1)

Virus Diseases (Phase 2)

Wounds and Injuries (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 10
  • # of Trial APIs: 13